Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2020

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Tailor-made Pharma Solutions

Make better informed business decisions with customized pharmaceutical consulting and marketing services that give you the edge over your competition.

Tailor-made solutions

Use the expertise and experience of Pharma Intelligence to produce custom solutions that are actionable, flexible, and tailored to help you successfully navigate biopharma portfolio management, commercial optimization, and R&D strategy. Benefit from:

A customized approach – we develop solutions to fit your situation
Joint problem/opportunity definition
Proprietary data and complementary market research
The experience of 500+ industry experts
Collaborative problem solving
Fact-based decisions and actionable recommendations
Ownership of final decisions and action plans

Discover new business opportunities, reduce risks, and make better, faster decisions with tailor-made pharmaceutical solutions from Pharma Intelligence.

Pharmaprojects

Find the right investigators and sites for your clinical trial using granular, real-world data.

Gain vital insight into study feasibility, site selection, and investigator prioritization with granular data from the new Informa Pharma Intelligence Patient Proximity API. Protect yourself against costly trial delays by using it to choose the right investigators with relevant and sizable patient proximity.

Topic Clinical trial optimization Clinical Trials

Full video
Scrip

India Lockdown Early Signs of Manufacturing Strains But Resolutions Underway

Pharmaceutical manufacturing in India is facing some early stress amid the new 21-day lock-down but both the industry and government machinery are actively engaged and working together to ensure that disruptions are minimized in the ‘pharmacy of the world.’

Topic Coronavirus

View article
Scrip

Tech Transfer Roundup: Universities And Biotechs Continue To Look For Ways To Combat COVID-19

AlloVir/Baylor, Soligenix/Hawaii and CEL-SCI/Georgia ink coronavirus collaborations, but deal-making continues in other areas as well, including Asklepios/UNC teaming on a gene therapy for Angelman syndrome and DeMelle licensing a targeted pancreatic cancer drug from Moffitt, among others.

Topic Coronavirus Medtech

View article
Scrip

Coronavirus Update: South Korea's Celltrion Progresses Antibody, Yancopoulos: 'The World Is Counting On Us'

Regeneron's head of R&D George Yancopoulos delivers some stirring words about the need to unify against the global threat posed by COVID-19.

Topic Coronavirus

View article
Scrip

Experts Say COVID-19 Battle Needs More Funding, Cooperation

Adequate funding and joined-up global cooperation are two top priorities needed to combat COVID-19, a panel of pharma executives told this year’s BIO-Europe Spring.

Topic Coronavirus

View article
Medtech Insight

COVID-19 Fact File: Global Diagnostic Test Pipeline

Medtech Insight is tracking the IVD companies manufacturing tests for SARS-CoV-2, the coronavirus that causes COVID-19.

Topic Coronavirus

View article
Biomedtracker, Trialtrove, Pharmaprojects, Scrip, Pink Sheet...

COVID-19 Infographic

Access the infographic below which explores the number of treatment drugs for COVID-19 currently in clinical trials or in development, events including progress updates, partnerships, regulatory and trial announcements etc, and the number of articles published on COVID-19 as of March 3, 2020. This data has been tracked and reported via Informa Pharma Intelligence’s clinical, regulatory and commercial data and analytics, and news and insight tools including Biomedtracker, Trialtrove, Pharmaprojects, Scrip, Pink Sheet, Medtech Insight, and Generics Bulletin etc.

Topic Coronavirus

View infographic
Medtech Insight

FDA Allowing Modifications To Ventilator Equipment To Bolster Supplies During COVID-19 Crisis

The US agency says it will not object to medtech manufacturers making minor modifications to the motors, tubing or software of medical ventilators – or even to pressing CPAP (continuous positive airway pressure) equipment into service to use as ventilators – during the COVID-19 public health emergency.

Topic Coronavirus Medtech

View article
Medtech Insight

Telehealth Sees Skyrocketing Demand Amid Regulatory Expansion, Hopes To Last Beyond COVID-19 Crisis

US telehealth companies are seeing skyrocketing demand for devices and services, which offers opportunities and challenges during this COVID-19 crisis.

Topic Coronavirus Medtech

View article
Biomedtracker

Biomedtracker Potential Pivots in 2020

In this infographic, we provide insight into key trials that are expecting developments in the approval process.

View infographic
Medtech Insight

Cepheid Nabs First FDA Authorization For Rapid-Response COVID-19 Test

A rapid-response test from Danaher business unit Cepheid will be the first quick COVID-19 diagnostic to reach the US market, the US FDA announced on 21 March.

Topic Coronavirus Medtech

View article
Generics Bulletin

Sandoz, Teva And Mylan Step Up On Hydroxychloroquine

To meet expected demand in the weeks and months ahead, Novartis' Sandoz has committed to donate up to 130 million doses of generic hydroxychloroquine – a treatment for malaria currently under investigation as a therapy to aid in the COVID-19 pandemic – while Teva and Mylan have also made strides, as the generics industry continues to play its part in tackling the coronavirus outbreak.

Topic Coronavirus

View article
In Vivo, HBW Insight, Pink Sheet, Scrip, Generics Bulletin, ...

Coronavirus: Keep up to date with Breaking News and Insight

Track the latest developments in the worldwide coronavirus outbreak and what it means for the pharma, medtech, generics and OTC industries with coverage from the Informa Pharma Intelligence Insights suite of tools. Get vital breaking news and penetrating analysis about the impact of this global health crisis.

Topic Coronavirus

Single report
Medtech Insight

‘We’re Not Making Hubcaps’: Why Trump’s Wartime Approach To Manufacturing Medtech For COVID-19

Two Hogan Lovells attorneys say the medical device industry is jittery about President Trump’s 18 March invocation of the Defense Production Act. That’s because the DPA gives the government broad authority to, among other things, order manufacturers to make particular products in a time of great national need. That can be a problem if those companies can’t make complex products like ventilators – or don’t make devices in the first place. After all, “we’re not making hubcaps. We’re making important devices,” Hogan Lovells partner Mike Heyl tells Medtech Insight.Is Making Industry Sweat.

Topic Coronavirus Medtech

View article
Generics Bulletin

Preserving Full Capacity Is Key To Global Coronavirus Reponse

Leaders around the world must do all they can to ensure that medicines manufacturing and the supply chain are operating at full capacity as part of efforts to tackle the coronavirus outbreak, global off-patent industry association the IGBA has urged.

Topic Coronavirus

View article

Latest headlines

Medtech Insight

27 Mar 2020

QUOTED. 27 March 2020. US FDA.

Link
HBW Insight

27 Mar 2020

The Race Is On To Launch COVID-19 Antibody Home-Test In The UK

Link
Pink Sheet

27 Mar 2020

A Look At The New Leadership Team At NICE

Link
Scrip

27 Mar 2020

Sanofi Joins mRNA COVID-19 Club With Translate Tie-Up

Link
Pink Sheet

27 Mar 2020

UK Attacks Pandemic With Funding For Drug And Vaccine Trials

Link
HBW Insight

27 Mar 2020

ECHA Supporting Efforts To Speed Disinfectants To European Market

Link
Medtech Insight

27 Mar 2020

Australia Proposes ‘Carving Out’ Certain Software Products From Medtech Regs

Link
Medtech Insight

27 Mar 2020

Did The UK Government Really Spurn EU Ventilator Procurement Support?

Link
Scrip

27 Mar 2020

Coronavirus Update: More Companies Join Therapeutics Accelerator, FDA Delays AdCom For First NASH Drug

Link
Medtech Insight

27 Mar 2020

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Link
Medtech Insight

27 Mar 2020

In A Bizarre Move, Trump Orders GM To Make Ventilators – Even Though The Auto Giant Already Is

Link
HBW Insight

27 Mar 2020

Recordati’s OTC Sales Lifted by Acquisitions And Italy

Link
Medtech Insight

27 Mar 2020

Start-Up Spotlight: Iraq War Veteran Deploys ‘Bone Paint’ To Combat Traumatic Injuries

Link
Scrip

27 Mar 2020

Dosing Guidance Lacking For Leading COVID-19 Antiviral Therapies, ASHP Analysis Shows

Link
Scrip

27 Mar 2020

Deal Watch: Coronavirus Collaborations Reflect Industry’s Full Press Pandemic Response

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Tailor-made Pharma Solutions

Tailor-made solutions

Pharma Intelligence latest insights

Find the right investigators and sites for your clinical trial using granular, real-world data.

India Lockdown Early Signs of Manufacturing Strains But Resolutions Underway

Tech Transfer Roundup: Universities And Biotechs Continue To Look For Ways To Combat COVID-19

Coronavirus Update: South Korea's Celltrion Progresses Antibody, Yancopoulos: 'The World Is Counting On Us'

Experts Say COVID-19 Battle Needs More Funding, Cooperation

COVID-19 Fact File: Global Diagnostic Test Pipeline

COVID-19 Infographic

FDA Allowing Modifications To Ventilator Equipment To Bolster Supplies During COVID-19 Crisis

Telehealth Sees Skyrocketing Demand Amid Regulatory Expansion, Hopes To Last Beyond COVID-19 Crisis

Biomedtracker Potential Pivots in 2020

Cepheid Nabs First FDA Authorization For Rapid-Response COVID-19 Test

Sandoz, Teva And Mylan Step Up On Hydroxychloroquine

Coronavirus: Keep up to date with Breaking News and Insight

‘We’re Not Making Hubcaps’: Why Trump’s Wartime Approach To Manufacturing Medtech For COVID-19

Preserving Full Capacity Is Key To Global Coronavirus Reponse

Latest headlines

QUOTED. 27 March 2020. US FDA.

The Race Is On To Launch COVID-19 Antibody Home-Test In The UK

A Look At The New Leadership Team At NICE

Sanofi Joins mRNA COVID-19 Club With Translate Tie-Up

UK Attacks Pandemic With Funding For Drug And Vaccine Trials

ECHA Supporting Efforts To Speed Disinfectants To European Market

Australia Proposes ‘Carving Out’ Certain Software Products From Medtech Regs

Did The UK Government Really Spurn EU Ventilator Procurement Support?

Coronavirus Update: More Companies Join Therapeutics Accelerator, FDA Delays AdCom For First NASH Drug

Abbott Launches Five-Minute POC Rapid COVID-19 Test

In A Bizarre Move, Trump Orders GM To Make Ventilators – Even Though The Auto Giant Already Is

Recordati’s OTC Sales Lifted by Acquisitions And Italy

Start-Up Spotlight: Iraq War Veteran Deploys ‘Bone Paint’ To Combat Traumatic Injuries

Dosing Guidance Lacking For Leading COVID-19 Antiviral Therapies, ASHP Analysis Shows

Deal Watch: Coronavirus Collaborations Reflect Industry’s Full Press Pandemic Response

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store